Sign up to save your podcasts
Or
Share Gordon Van Slyke: A Trial Participant’s Inside Look at New Alzheimer’s Drug Leqembi
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gordon Van Slyke: A Trial Participant’s Inside Look at New Alzheimer’s Drug Leqembi
When Gordon Van Slyke, 75, decided to participate in the phase drug trials for Eisai and Biogen’s new monoclonal antibody drug Leqembi (lecanemab), it was his family history with Alzheimer’s that motivated him.
Read more about his story:
https://www.beingpatient.com/lecanemab-leqembi-trial-participant-story/
View all episodes
By Being Patient
4.6
99 ratings
When Gordon Van Slyke, 75, decided to participate in the phase drug trials for Eisai and Biogen’s new monoclonal antibody drug Leqembi (lecanemab), it was his family history with Alzheimer’s that motivated him.
Read more about his story:
https://www.beingpatient.com/lecanemab-leqembi-trial-participant-story/
More shows like Brain Talk | Being Patient for Alzheimer's Patients and Caregivers
View all
The Human Upgrade: Biohacking for Longevity & Performance
7,219 Listeners
Retirement Answer Man
1,315 Listeners
10% Happier with Dan Harris
12,733 Listeners
The Energy Blueprint Podcast
702 Listeners
The mindbodygreen Podcast
2,034 Listeners
Dr. Berg’s Healthy Keto and Intermittent Fasting Podcast
1,693 Listeners
The Genius Life
4,907 Listeners
Dhru Purohit Show
3,523 Listeners
The Dr. Hyman Show
9,228 Listeners
The Peter Attia Drive
8,971 Listeners
Life Time Talks
147 Listeners
Chasing Life
8,181 Listeners
ZOE Science & Nutrition
2,062 Listeners
The Mel Robbins Podcast
20,249 Listeners
Truth, Lies & Alzheimer's
16 Listeners